Literature DB >> 27475408

Factors associated with having a medical marijuana card among Veterans with recent substance use in VA outpatient treatment.

Alan K Davis1, Erin E Bonar2, Mark A Ilgen3, Maureen A Walton4, Brian E Perron5, Stephen T Chermack3.   

Abstract

Psychiatric symptoms, somatic problems, and co-occurring substance use have been associated with medical marijuana consumption among civilian patients with substance use disorders. It is possible that these factors may impact Veterans' ability to engage in or adhere to mental health and substance use disorder treatment. Therefore, we examined whether psychiatric functioning, substance use, and somatic problems were associated with medical marijuana use among Veterans receiving substance use disorder and/or mental health treatment. Participants (n=841) completed screening measures for a randomized controlled trial and 67 (8%) reported that they had a current medical marijuana card. Most of these participants (78%) reported using marijuana to treat severe/chronic pain. Significant bivariate differences revealed that, compared to participants without a medical marijuana card, those with a card were more likely to be in a middle income bracket, unemployed, and they had a significantly higher number of recent days of marijuana use, synthetic marijuana use, and using sedatives prescribed to them. Additionally, a significantly higher proportion of participants with a medical marijuana card scored above the clinical cutoff for posttraumatic stress disorder (PTSD) symptoms, had significantly higher severity of sleep-related problems, and reported a higher level of pain. These findings highlight the co-occurrence of substance use, PTSD symptoms, sleep-related problems, and chronic pain among Veterans who use medical marijuana. Future research should investigate the inter-relationships among medical marijuana use and other clinical issues (e.g., PTSD symptoms, sleep, pain) over time, and potential implications of medical marijuana use on treatment engagement and response.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cannabis; Marijuana; Substance use problems; Treatment; Veterans

Mesh:

Substances:

Year:  2016        PMID: 27475408     DOI: 10.1016/j.addbeh.2016.07.006

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  10 in total

1.  Cannabis use disorder and male sex predict medical cannabis card status in a sample of high risk adolescents.

Authors:  Janet Kim; Marilyn E Coors; Susan E Young; Kristen M Raymond; Christian J Hopfer; Tamara L Wall; Robin P Corley; Sandra A Brown; Joseph T Sakai
Journal:  Drug Alcohol Depend       Date:  2017-12-02       Impact factor: 4.492

2.  Factors associated with alcohol consumption among medical cannabis patients with chronic pain.

Authors:  Alan K Davis; Maureen A Walton; Kipling M Bohnert; Carrie Bourque; Mark A Ilgen
Journal:  Addict Behav       Date:  2017-10-12       Impact factor: 3.913

Review 3.  Prevalence, reasons, perceived effects, and correlates of medical marijuana use: A review.

Authors:  Ji-Yeun Park; Li-Tzy Wu
Journal:  Drug Alcohol Depend       Date:  2017-05-16       Impact factor: 4.492

4.  A Mapping Literature Review of Medical Cannabis Clinical Outcomes and Quality of Evidence in Approved Conditions in the USA from 2016 to 2019.

Authors:  Sebastian Jugl; Aimalohi Okpeku; Brianna Costales; Earl J Morris; Golnoosh Alipour-Haris; Juan M Hincapie-Castillo; Nichole E Stetten; Ruba Sajdeya; Shailina Keshwani; Verlin Joseph; Yahan Zhang; Yun Shen; Lauren Adkins; Almut G Winterstein; Amie Goodin
Journal:  Med Cannabis Cannabinoids       Date:  2021-02-25

5.  Comparison of Medical Cannabis Use Reported on a Confidential Survey vs Documented in the Electronic Health Record Among Primary Care Patients.

Authors:  Gwen T Lapham; Theresa E Matson; David S Carrell; Jennifer F Bobb; Casey Luce; Malia M Oliver; Udi E Ghitza; Clarissa Hsu; Kendall C Browne; Ingrid A Binswanger; Cynthia I Campbell; Andrew J Saxon; Ryan Vandrey; Gillian L Schauer; Rosalie Liccardo Pacula; Michael A Horberg; Steffani R Bailey; Erin A McClure; Katharine A Bradley
Journal:  JAMA Netw Open       Date:  2022-05-02

Review 6.  Affect and cannabis use in daily life: a review and recommendations for future research.

Authors:  Andrea M Wycoff; Jane Metrik; Timothy J Trull
Journal:  Drug Alcohol Depend       Date:  2018-08-15       Impact factor: 4.492

7.  Prevalence of Medical Cannabis Use and Associated Health Conditions Documented in Electronic Health Records Among Primary Care Patients in Washington State.

Authors:  Theresa E Matson; David S Carrell; Jennifer F Bobb; David J Cronkite; Malia M Oliver; Casey Luce; Udi E Ghitza; Clarissa W Hsu; Cynthia I Campbell; Kendall C Browne; Ingrid A Binswanger; Andrew J Saxon; Katharine A Bradley; Gwen T Lapham
Journal:  JAMA Netw Open       Date:  2021-05-03

8.  Use of Medicinal Cannabis and Synthetic Cannabinoids in Post-Traumatic Stress Disorder (PTSD): A Systematic Review.

Authors:  Laura Orsolini; Stefania Chiappini; Umberto Volpe; Domenico De Berardis; Roberto Latini; Gabriele Duccio Papanti; And John Martin Corkery
Journal:  Medicina (Kaunas)       Date:  2019-08-23       Impact factor: 2.430

9.  Medicinal versus Recreational Cannabis Use among Returning Veterans.

Authors:  Jane Metrik; Shayna S Bassett; Elizabeth R Aston; Kristina M Jackson; Brian Borsari
Journal:  Transl Issues Psychol Sci       Date:  2018-03

10.  US Epidemiology of Cannabis Use and Associated Problems.

Authors:  Deborah S Hasin
Journal:  Neuropsychopharmacology       Date:  2017-08-30       Impact factor: 7.853

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.